Sign up to save your podcasts
Or
Share Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
More shows like Neurology Today in 5
View all
Neurology® Podcast
291 Listeners
NEJM This Week
322 Listeners
Practical Neurology Podcast
50 Listeners
This Week in Cardiology
873 Listeners
JAMA Clinical Reviews
507 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Medical News
87 Listeners
BMJ Best Practice Podcast
23 Listeners
The Clinical Problem Solvers
516 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
362 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
367 Listeners
The Lancet Neurology in conversation with
5 Listeners
Continuum Audio
81 Listeners